| 1 |
34474172 | Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: Systematic review and meta-analysis. | 2022 Jan |
2 |
| 2 |
33272733 | Optimization of azathioprine dose in combined treatment with anti-TNF-alpha in inflammatory bowel disease. | 2021 May |
1 |
| 3 |
33283312 | Treatment-based risk stratification of infections in inflammatory bowel disease: A comparison between anti-tumor necrosis factor-α and nonbiological exposure in real-world setting. | 2021 Jul |
1 |
| 4 |
31532479 | The Cost-effectiveness of Initial Immunomodulators or Infliximab Using Modern Optimization Strategies for Crohn's Disease in the Biosimilar Era. | 2020 Feb 11 |
2 |
| 5 |
31980448 | Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trial. | 2020 Jul |
2 |
| 6 |
32547497 | A Remarkable Response of Granulomatous Hypophysitis to Infliximab in a Patient With a Background of Crohn's Disease-A Case Report. | 2020 |
1 |
| 7 |
32689833 | Combination therapy in inflammatory bowel disease patients: do we need to maximize the dose of azathioprine? | 2020 Aug |
1 |
| 8 |
33311945 | Active tuberculosis in inflammatory bowel disease patients under treatment from an endemic area in Latin America. | 2020 Nov 28 |
1 |
| 9 |
29754190 | Allergic and Immunologic Perspectives of Inflammatory Bowel Disease. | 2019 Oct |
1 |
| 10 |
30748107 | Effects of azathioprine and its metabolites on inflammatory cytokines in human nasal polyp organ cultures. | 2019 Jun |
1 |
| 11 |
30889246 | The Inflammatory Bowel Disease Drug Azathioprine Induces Autophagy via mTORC1 and the Unfolded Protein Response Sensor PERK. | 2019 Aug 20 |
1 |
| 12 |
31694755 | Treatment of anti-TNF-related paradoxic palmoplantar psoriasis in Behçet's disease with azathioprine. | 2019 Nov-Dec |
1 |
| 13 |
28584644 | Evaluation of tumor necrosis factor (TNF)-α mRNA expression level and the rs1799964 polymorphism of the TNF-α gene in peripheral mononuclear cells of patients with inflammatory bowel diseases. | 2017 Jun |
1 |
| 14 |
28679512 | Guillain-Barré syndrome in association with antitumour necrosis factor therapy: a case of mistaken identity. | 2017 Jul 5 |
1 |
| 15 |
28922253 | Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort. | 2017 Nov |
1 |
| 16 |
27548499 | Are Immunosuppressants Becoming Obsolete? | 2016 |
1 |
| 17 |
25707965 | Clinical impact of concomitant immunomodulators on biologic therapy: Pharmacokinetics, immunogenicity, efficacy and safety. | 2015 Mar |
2 |
| 18 |
25789922 | Concomitant use of azathioprine/6-mercaptopurine decreases the risk of anti-TNF-induced skin lesions. | 2015 Apr |
2 |
| 19 |
25874518 | Azathioprine discontinuation earlier than 6 months in Crohn's disease patients started on anti-TNF therapy is associated with loss of response and the need for anti-TNF dose escalation. | 2015 Apr |
5 |
| 20 |
26252649 | Combination of Azathioprine and Aminosalicylate Treatment Prevent Risk of Cardiovascular Disease in Women with Ulcerative Colitis by Reducing Inflammation. | 2015 Aug 7 |
1 |
| 21 |
26557831 | Medical Therapy of Active Ulcerative Colitis. | 2015 Aug |
1 |
| 22 |
24074969 | [Sustained response with tocilizumab in a case of refractory relapsing polychondritis]. | 2014 Mar |
1 |
| 23 |
24884302 | Anti-tumor necrosis factor agents reduce corticosteroid use compared with azathioprine in patients with Crohn's disease. | 2014 Sep |
2 |
| 24 |
25105206 | Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials. | 2014 Nov |
1 |
| 25 |
25182201 | Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis. | 2014 Dec |
1 |
| 26 |
25531359 | Role of immunosuppressives in special situations: perianal disease and postoperative period. | 2014 |
1 |
| 27 |
24379584 | Synergistic effect of interleukin-10-receptor variants in a case of early-onset ulcerative colitis. | 2013 Dec 14 |
1 |
| 28 |
22853939 | Improvement of anti-TNFα antibody-induced pustular psoriasis by azathioprine. | 2012 Jul-Aug |
1 |
| 29 |
20120429 | Recalcitrant cicatricial pemphigoid treated with the anti-TNF-alpha agent etanercept. | 2010 Jan |
1 |
| 30 |
20926883 | State-of-the-art: Immunosuppression and biologic therapy. | 2010 |
1 |
| 31 |
19584951 | Immune responses in autoimmune hepatitis: effect of prednisone and azathioprine treatment: case report. | 2009 Jun 30 |
1 |
| 32 |
18597652 | Pharmacogenetics of Crohn's disease. | 2008 Jul |
1 |
| 33 |
17713889 | [Crohn's disease--infliximab, adalimumab and certolizumab-pegol: clinical value of anti-TNF-alpha treatment]. | 2007 Aug |
1 |
| 34 |
17110316 | Malignancies and soluble tumor antigens in rheumatic diseases. | 2006 Nov |
1 |
| 35 |
17149058 | Behçet disease: recommendation for clinical management of mucocutaneous lesions. | 2006 Dec |
2 |
| 36 |
14614765 | Tumour necrosis factor in sarcoidosis and its potential for targeted therapy. | 2003 |
1 |
| 37 |
11354662 | Aza analogues of thalidomide: synthesis and evaluation as inhibitors of tumor necrosis factor-alpha production in vitro. | 2001 Apr |
1 |
| 38 |
10631636 | Assessing multiple sclerosis activity: is the in vitro production of tumor necrosis factor-alpha, interleukins 2, 6, 4, and 10, and immunoglobulin G of value? | 1999 Nov |
1 |
| 39 |
9762674 | In vitro cytokine profiles as indicators of relapse activity and clinical course in multiple sclerosis. | 1998 Jun |
2 |
| 40 |
9050957 | Immunological monitoring of azathioprine treatment in multiple sclerosis patients. | 1997 Mar |
1 |
| 41 |
7694584 | Effect of dexamethasone, 6-mercaptopurine and cyclosporine A on intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression. | 1993 Oct 19 |
1 |